Scope Biosciences raised €500k in a funding round in Oct 2023. The company is based in Wageningen, Netherlands. Investors in the round: OostNL, SHIFT Invest. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €500k
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
